PIONAORIGIN ARCHIVE

PIONA ORIGIN ARCHIVE / 01

DERMA ORIGIN · MANUFACTURING RECORD · COSMETIC BOUNDARY

Before a formula,there is an ingredient standard.

PIONA begins with ZERONE CELLVANE's PDRN research and manufacturing background. This archive keeps company technology, ingredient numbers, cell research, and everyday cosmetic benefits in separate evidence layers rather than merging them into one efficacy claim.

Now, switch on your skin's Energy.

01 / THE MAKER

ZERONE CELLVANE

It begins with a company that has researched and manufactured PDRN.

ZERONE CELLVANE is a PDRN research and manufacturing company founded by physician Dr. Deok-gyu Kim. Its API registration and prescription-product development history explain the company's PDRN background; they do not make PIONA cosmetics a pharmaceutical product.

FOUNDERDEOK-GYU KIM

Physician founder

RESEARCHPDRN

Ingredient research and manufacturing background

LINEAGEAPI → DAILY CARE

Company history and cosmetic status remain separate

Making the ingredient's background visible is where the PIONA dermal standard begins.
02 / PRISM TECHNOLOGY

UNIFORM LOW-MOLECULAR-WEIGHT PLATFORM

Not a race to be smallest,but a method for a controlled range.

PRISM is ZERONE CELLVANE's manufacturing technology for controlling the size range of nucleic-acid fragments through a physical process using defined pressure and temperature conditions. Korean Patent No. 10-2701140 records a method for producing uniform-sized nucleic acid fragments.

DRAG / COMPARE THE TECHNOLOGY RECORDS

Drag left or right to compare the two technology records

Drag the handle or use the arrow keys.

ZERONE CELLVANE INTERNAL TECHNOLOGY RECORDS · NOT A MARKET-WIDE PDRN, SKIN-ABSORPTION, OR FINISHED-PRODUCT EFFICACY COMPARISON.

EARLIER RECORD2019 · 80–600 bpBROAD DISTRIBUTION
RECENT RECORD2024 · 60–100 bpNARROWER DISTRIBUTION
ZERONE CELLVANE IR · INTERNAL TECHNOLOGY RECORDPatent embodiment range · 50–150 nt

The annual IR ranges and patent embodiment are technology records. They are not a confirmed specification for PIONA's finished formula and do not establish skin absorption or human efficacy.

03 / THREE NUMBERS

THREE NUMBERS, THREE DIFFERENT QUESTIONS

A larger number does notmean the same thing.

Purity, formula concentration, and molecular size measure different things. No single number can rank PDRN quality or cosmetic efficacy on its own.

0199.9%

Ingredient purity reference

How much of the pre-formulation ingredient is the intended material?

Proposal materials
02500 ppm

Finished-formula concentration reference

How much ingredient is included in the finished formula?

Proposal materials
0360–100 bp

Molecular-size range record

What range appears in the company's 2024 IR electrophoresis band?

ZERONE CELLVANE IR 2026
Just as the grade of a coffee bean and the amount used in one cup answer different questions, ingredient purity and finished-formula ppm cannot be read as the same score.
04 / THE NAME

WHAT MD. PDRN MEANS

MD is not a drug designation.It names the research background.

PIONA uses MD. PDRN as a brand name that makes the PDRN research and manufacturing background of physician-founded ZERONE CELLVANE visible. PIONA products are cosmetics for daily moisture and skin-texture care; they are not drugs or medical devices.

MD. PDRN = MAKER'S DISCIPLINE · MEDICAL RESEARCH LINEAGE · DAILY DERMAL CARE
05 / FROM ORIGIN TO ENERGY

Now, switch on your skin's Energy.

Not an absorption promise,but a record of the research question.

Ingredient-manufacturing precision, mitochondrial observations in cell conditions, and everyday cosmetic benefits are different evidence layers. PIONA does not collapse them into one efficacy claim.

01 · SOURCE

Ingredient standard

Records of origin, refinement, and molecular range

02 · RESEARCH

Cell research

Mitochondria-related observations under HS68 cell conditions

03 · RITUAL

Daily cosmetic

Everyday care for moisture, texture, and a supple-looking finish

Cell studies are not human clinical trials. The Energy perspective does not guarantee skin absorption or therapeutic effects from PIONA's finished products.

SOURCE LEDGER / VERIFIED RECORDS

  1. 01Korean Patent No. 10-2701140
  2. 02ZERONE CELLVANE P-T PDRN official page
  3. 03ZERONE CELLVANE company introduction
  4. 04Korean MFDS cosmetics advertising guideline
  5. 05ZERONE CELLVANE Investor Relations 2026

The IR figures reproduce a technology record from the user-provided ZERONE CELLVANE Investor Relations 2026 page. Until a public ingredient specification is available, they are not treated as the confirmed specification of the ingredient used in PIONA.